Published in Int J Epidemiol on August 19, 2004
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull (2008) 2.09
Formative research on perceptions of biobanking: what community members think. J Cancer Educ (2012) 2.03
Genetic epidemiology and primary care. Br J Gen Pract (2006) 1.89
Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol (2008) 1.17
Patients' willingness to participate in a breast cancer biobank at screening mammogram. Breast Cancer Res Treat (2012) 0.98
Randomised by (your) god: robust inference from an observational study design. J Epidemiol Community Health (2006) 0.93
Of genomics and public health: Building public "goods"? CMAJ (2005) 0.88
Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role? J Gen Intern Med (2009) 0.87
Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks. J Cancer Educ (2014) 0.86
The era of genomic epidemiology. Neuroepidemiology (2009) 0.84
The challenge of developing evidence-based genetics health care in practice. Fam Cancer (2006) 0.83
Assessing needs and assets for building a regional network infrastructure to reduce cancer related health disparities. Eval Program Plann (2013) 0.83
Sample size requirements to detect the effect of a group of genetic variants in case-control studies. Emerg Themes Epidemiol (2008) 0.81
Differences in preferences for models of consent for biobanks between Black and White women. J Community Genet (2015) 0.79
Biobank attributes associated with higher patient participation: a randomized study. Eur J Hum Genet (2016) 0.78
Contributing to research via biobanks: what it means to cancer patients. Health Expect (2012) 0.78
Contributions of ethnicity to differential item functioning of cannabis abuse and dependence symptoms. J Stud Alcohol Drugs (2013) 0.77
Assessment of systematic effects of methodological characteristics on candidate genetic associations. Hum Genet (2012) 0.77
eMERGE Phenome-Wide Association Study (PheWAS) identifies clinical associations and pleiotropy for stop-gain variants. BMC Med Genomics (2016) 0.75
Assessing the social meaning, value and implications of research in genomics. J Epidemiol Community Health (2007) 0.75
Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet (2008) 30.94
The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med (2007) 9.48
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol (2007) 4.96
Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53
How many genes underlie the occurrence of common complex diseases in the population? Int J Epidemiol (2005) 4.46
Cleft lip and palate. Lancet (2009) 4.29
Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2011) 4.22
The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol (2010) 4.04
Disruption of an AP-2alpha binding site in an IRF6 enhancer is associated with cleft lip. Nat Genet (2008) 4.04
Can family history be used as a tool for public health and preventive medicine? Genet Med (2002) 3.76
A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet (2008) 3.25
Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol (2002) 3.23
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology (2003) 2.96
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol (2006) 2.66
Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol (2009) 2.45
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med (2009) 2.39
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol (2010) 2.23
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med (2010) 1.98
Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol (2005) 1.92
Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol (2004) 1.91
STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest (2009) 1.82
GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics (2008) 1.75
Vitamin D status of Canadians as measured in the 2007 to 2009 Canadian Health Measures Survey. Health Rep (2010) 1.75
Risk factors for injury among high school football players. Epidemiology (2009) 1.73
Systematic review: family history in risk assessment for common diseases. Ann Intern Med (2009) 1.70
Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. Am J Epidemiol (2003) 1.66
Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak (2010) 1.66
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health (2002) 1.61
Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med (2009) 1.60
An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med (2004) 1.57
Knowledge integration at the center of genomic medicine. Genet Med (2012) 1.54
Occupational risk factors for low grade and high grade glioma: results from an international case control study of adult brain tumours. Int J Cancer (2005) 1.54
Citizens' values regarding research with stored samples from newborn screening in Canada. Pediatrics (2012) 1.48
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet (2009) 1.47
Addressing the challenges of cleft lip and palate research in India. Indian J Plast Surg (2009) 1.46
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
A prospective study of injury incidence among North Carolina high school athletes. Am J Epidemiol (2006) 1.44
A network of investigator networks in human genome epidemiology. Am J Epidemiol (2005) 1.43
Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med (2006) 1.43
Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health (2002) 1.41
Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies. Int J Epidemiol (2011) 1.41
5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev (2002) 1.39
Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res (2002) 1.38
HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr (2002) 1.37
Folate intake, markers of folate status and oral clefts: is the evidence converging? Int J Epidemiol (2008) 1.37
Genetic epidemiology with a capital E, ten years after. Genet Epidemiol (2011) 1.34
Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics (2008) 1.31
Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J Natl Cancer Inst (2012) 1.30
A P3G generic access agreement for population genomic studies. Nat Biotechnol (2013) 1.28
Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS (2002) 1.27
Organochlorine exposure and age at natural menopause. Epidemiology (2002) 1.26
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol (2009) 1.25
Predictive genetic testing for type 2 diabetes. BMJ (2006) 1.24
Methods for meta-analyses of genome-wide association studies: critical assessment of empirical evidence. Am J Epidemiol (2012) 1.24
An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics (2007) 1.24
Understanding sickle cell carrier status identified through newborn screening: a qualitative study. Eur J Hum Genet (2009) 1.22
After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial. BJOG (2009) 1.21
Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health (2011) 1.21
Family history and improving health. Evid Rep Technol Assess (Full Rep) (2009) 1.17
Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol (2008) 1.17
Family history assessment: strategies for prevention of cardiovascular disease. Am J Prev Med (2003) 1.15
STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol (2009) 1.13
An automatic method to generate domain-specific investigator networks using PubMed abstracts. BMC Med Inform Decis Mak (2007) 1.11
Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev (2004) 1.11
STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med (2009) 1.11
Family history of heart disease and cardiovascular disease risk-reducing behaviors. Genet Med (2004) 1.10
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer (2014) 1.10
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. PLoS Med (2011) 1.09
GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet (2011) 1.08
The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol (2003) 1.07
The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev (2005) 1.06
Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med (2007) 1.06
Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): Trial design. Contemp Clin Trials (2006) 1.05
Strengthening the reporting of genetic risk prediction studies: the GRIPS statement. Eur J Epidemiol (2011) 1.04
Systems-based candidate genes for human response to influenza infection. Infect Genet Evol (2009) 1.04
Achieving the "triple aim" for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework. Genet Med (2012) 1.04
Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control (2012) 1.02
Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol (2007) 1.01
Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians. J Inherit Metab Dis (2011) 1.01
Dietary flavonoid intake and colorectal cancer: a case-control study. Br J Nutr (2009) 0.99
Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int J Epidemiol (2012) 0.99
The utility and predictive value of combinations of low penetrance genes for screening and risk prediction of colorectal cancer. Hum Genet (2010) 0.99
Genome-wide association studies in pharmacogenomics: untapped potential for translation. Genome Med (2009) 0.98
Informing parents about expanded newborn screening: influences on provider involvement. Pediatrics (2009) 0.97
Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One (2013) 0.96